← Back to headlines
Eli Lilly's New Oral Weight-Loss Pill Foundayo Approved by FDA
Eli Lilly's new GLP-1 weight-loss pill, Foundayo, which is the first oral GLP-1 not requiring fasting, has been approved by the Food and Drug Administration and has shown effectiveness in clinical trials, with one user losing 25 pounds.
4 Apr, 10:09 — 4 Apr, 10:09



